| Segment Reporting [Text Block] |
The Company follows ASC 280, “Segment Reporting,” which establishes standards for companies to report information about operating segments, geographic areas and major customers. The accounting policies of each reportable segment are the same as those described in the summary of significant accounting policies (see Note 1 to the Company’s Consolidated Financial Statements).
The Company reports segment information based on the management approach, which designates the internal reporting used by the Chief Operating Decision Makers (“CODMs”), who were Bradley Vizi, Chief Executive Officer, and Kevin Miller, Chief Financial Officer. The Company’s CODMs are responsible for making decisions regarding the Company’s business, including resource allocations and performance assessments based on historical and future segment revenue, operating expenses, and operating income (loss).
The tables below summarize the results of operations and total assets by segment provided to the CODMs. Segment operating income (loss) includes selling, general, and administrative expenses directly attributable to that segment. The following tables reflect the results of the reportable segments consistent with the Company’s management system:
| Thirteen Weeks Ended July 4, 2026 | | Specialty Health Care | | | Engineering | | | Life Sciences, Data & Solutions | | | Corporate | | | Total | |
| Revenue | | $ | 44,728 | | | $ | 39,525 | | | $ | 9,563 | | | $ | - | | | $ | 93,816 | |
| Cost of services | | | 31,566 | | | | 32,484 | | | | 5,684 | | | | - | | | | 69,734 | |
| Gross profit | | | 13,162 | | | | 7,041 | | | | 3,879 | | | | - | | | | 24,082 | |
| Selling, general and administrative | | | 6,624 | | | | 3,140 | | | | 1,157 | | | | 4,647 | | | | 15,568 | |
| Depreciation and amortization of property and equipment | | | 121 | | | | 227 | | | | 37 | | | | 173 | | | | 558 | |
| Operating income (loss) | | $ | 6,417 | | | $ | 3,674 | | | $ | 2,685 | | | $ | (4,820 | ) | | $ | 7,956 | |
| Total assets as of July 4, 2026 | | $ | 40,856 | | | $ | 64,003 | | | $ | 14,332 | | | $ | 14,815 | | | $ | 134,006 | |
| Property and equipment acquired | | $ | 48 | | | $ | 42 | | | $ | - | | | $ | 14 | | | $ | 104 | |
| Thirteen Weeks Ended June 28, 2025 | | Specialty Health Care | | | Engineering | | | Life Sciences, Data & Solutions | | | Corporate | | | Total | |
| Revenue | | $ | 42,822 | | | $ | 26,521 | | | $ | 8,823 | | | $ | - | | | $ | 78,166 | |
| Cost of services | | | 30,545 | | | | 20,031 | | | | 5,313 | | | | - | | | | 55,889 | |
| Gross profit | | | 12,277 | | | | 6,490 | | | | 3,510 | | | | - | | | | 22,277 | |
| Selling, general and administrative | | | 6,114 | | | | 3,016 | | | | 1,490 | | | | 4,655 | | | | 15,275 | |
| Depreciation and amortization of property and equipment | | | 87 | | | | 159 | | | | 38 | | | | 117 | | | | 401 | |
| Operating income (loss) | | $ | 6,076 | | | $ | 3,315 | | | $ | 1,982 | | | $ | (4,772 | ) | | $ | 6,601 | |
| Total assets as of June 28, 2025 | | $ | 48,201 | | | $ | 58,284 | | | $ | 16,492 | | | $ | 12,609 | | | $ | 135,586 | |
| Property and equipment acquired | | $ | 75 | | | $ | 176 | | | $ | (3 | ) | | $ | 225 | | | $ | 473 | |
| Twenty-Six Weeks Ended July 4, 2026 | | Specialty Health Care | | | Engineering | | | Life Sciences, Data & Solutions | | | Corporate | | | Total | |
| Revenue | | $ | 92,832 | | | $ | 65,662 | | | $ | 18,360 | | | $ | - | | | $ | 176,854 | |
| Cost of services | | | 66,229 | | | | 53,320 | | | | 11,202 | | | | - | | | | 130,751 | |
| Gross profit | | | 26,603 | | | | 12,342 | | | | 7,158 | | | | - | | | | 46,103 | |
| Selling, general and administrative | | | 13,308 | | | | 5,843 | | | | 2,354 | | | | 9,592 | | | | 31,097 | |
| Depreciation and amortization of property and equipment | | | 243 | | | | 450 | | | | 73 | | | | 346 | | | | 1,112 | |
| Operating income (loss) | | $ | 13,052 | | | $ | 6,049 | | | $ | 4,731 | | | $ | (9,938 | ) | | $ | 13,894 | |
| Total assets as of July 4, 2026 | | $ | 40,856 | | | $ | 64,003 | | | $ | 14,332 | | | $ | 14,815 | | | $ | 134,006 | |
| Property and equipment acquired | | $ | 81 | | | $ | 83 | | | $ | - | | | $ | 37 | | | $ | 201 | |
| Twenty-Six Weeks Ended June 28, 2025 | | Specialty Health Care | | | Engineering | | | Life Sciences, Data & Solutions | | | Corporate | | | Total | |
| Revenue | | $ | 86,105 | | | $ | 58,663 | | | $ | 17,871 | | | $ | - | | | $ | 162,639 | |
| Cost of services | | | 61,624 | | | | 45,989 | | | | 10,771 | | | | - | | | | 118,384 | |
| Gross profit | | | 24,481 | | | | 12,674 | | | | 7,100 | | | | - | | | | 44,255 | |
| Selling, general and administrative | | | 12,043 | | | | 6,150 | | | | 2,916 | | | | 9,137 | | | | 30,246 | |
| Depreciation and amortization of property and equipment | | | 187 | | | | 330 | | | | 78 | | | | 230 | | | | 825 | |
| Operating income (loss) | | $ | 12,251 | | | $ | 6,194 | | | $ | 4,106 | | | $ | (9,367 | ) | | $ | 13,184 | |
| Total assets as of June 28, 2025 | | $ | 48,201 | | | $ | 58,284 | | | $ | 16,492 | | | $ | 12,609 | | | $ | 135,586 | |
| Property and equipment acquired | | $ | 129 | | | $ | 242 | | | $ | 32 | | | $ | 497 | | | $ | 900 | |
The Company derives a majority of its revenue from offices in the United States. Revenue reported for each operating segment is all from external customers. The Company is domiciled in the United States, and its segments operate in the United States, Canada, Puerto Rico, Europe, and the Philippines. Revenue by geographic area for the thirteen and twenty-six weeks ended July 4, 2026, and June 28, 2025, was as follows:
| | | Thirteen Weeks Ended | | | Twenty-Six Weeks Ended | |
| | | July 4, 2026 | | | June 28, 2025 | | | July 4, 2026 | | | June 28, 2025 | |
| Revenue | | | | | | | | | | | | | | | | |
| United States | | $ | 88,146 | | | $ | 73,226 | | | $ | 165,886 | | | $ | 152,064 | |
| Canada | | | 1,211 | | | | 1,943 | | | | 2,515 | | | | 3,859 | |
| Puerto Rico | | | 1,656 | | | | 1,544 | | | | 3,416 | | | | 3,151 | |
| Europe | | | 2,803 | | | | 1,453 | | | | 5,037 | | | | 3,565 | |
| | | $ | 93,816 | | | $ | 78,166 | | | $ | 176,854 | | | $ | 162,639 | |
Total assets by geographic area as of the reported periods were as follows:
| | | July 4, 2026 | | | January 3, 2026 | |
| Total assets | | | | | | | | |
| United States | | $ | 118,930 | | | $ | 123,021 | |
| Canada | | | 1,804 | | | | 1,828 | |
| Puerto Rico | | | 2,364 | | | | 2,637 | |
| Europe | | | 10,402 | | | | 6,594 | |
| Philippines | | | 506 | | | | 317 | |
| | | $ | 134,006 | | | $ | 134,397 | |
|